-+ 0.00%
-+ 0.00%
-+ 0.00%

SPYRE THERAPEUTICS SHARES DOWN 12.4% PREMARKET AFTER CO'S EXPERIMENTAL DRUG FAILS TO MEET THRESHOLD FOR MONOTHERAPY DEVELOPMENT IN RHEUMATOID ARTHRITIS

Reuters·08/26/2026 08:57:47

Please log in to view news